Fri, Aug 29, 2014, 2:34 AM EDT - U.S. Markets open in 6 hrs 56 mins

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bluvit74 bluvit74 Dec 3, 2012 11:52 AM Flag

    TEXTBOOK

    TEXTBOOK shakeout you mean . . traders and trailing stops are`easy pray for "the best of breed" ..are you short EXEL at 4.64? ..

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Listen COCKROACH..I've ben at this game for over TWO decades and know the game well. If you think for a second you and all the other "new aliases" who popped up on this board over the past 8 weeks are "clever" to people in my league...you're a fool. Is Johnny ordering CHINESE FOOD for you dolts IN today so you can hammer on those computers while you stuff your faces with MSG and Calico cat? LMAO

      You fools have absolutely no clue who I am. I know where she is going to land 'cause I know where the HF wants it. This next trade will be another winner :-)

      • 2 Replies to nomad_celcius12
      • Have you been calling people names and demeaning people for ALL those decades too?I pity folks like you.

      • Hi nomad - was checking your posts before and after the fall. You clearly know the game here. I don't. Not being a biotech expert i was indeed surprised at the 1bl market cap (pretty usual here for a biotech) but for such a small expected revenue and huge (i mean huge) debt (north of the usuals in biotech). My life insurance is full and 10% profit is not what i'm after. I'm ready to loose some money on a biotech as it's apparently the next big thing.
        A friend recently recommended this company: Please could you have a look when you have time at Provectus Pharma. Pvct. They are waiting for Spa recipient (at any time apparently..), NO DEBT, money in the bank (but probably not enough for a full phase3 trial), market cap of 70M (with a market cap target amongst investors and the board of 1Bln). Pipes: Melanoma cancer, derm. Management over-pays itself but data seems exceptional, if not hard-to-believe...Thanks much for your views on this company and market. Kind regards Laurence, Paris, France.

 
EXEL
4.04-0.08(-1.94%)Aug 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.